News
06.24.08 | Genocea Selected as one of top 15 biotech companies of 2008
06.05.08 | Genocea, PATH and Children's Hospital Boston partner to develop pneumococcal vaccine
04.23.08 | Genocea Wins "Best Vaccine Startup" at World Vaccine Congress
03.15.08 | Darren Higgins featured on cover of Human Vaccines magazine
12.27.07 | Genocea featured in Forbes story on "Next Generation Vaccines"
12.18.07 | Genocea licenses portfolio of vaccine targets from Harvard Medical School
08.21.07 | Genocea appoints Adel Mahmoud and Robert Finberg to Scientific Advisory Board
06.20.07 | Vaccine expert George Siber joins Genocea Biosciences as Executive Chairman
05.16.07 | Genocea featured in The New York Times - Warding Off Diseases, Many Vaccines at a Time
03.19.07 | Ian Gust, Former Director of Research & Development at CSL Ltd, joins Genocea's Scientific Advisory Board
02.23.07 | Genocea featured in Mass High Tech article - Harvard Heavy Hitters Launch New Venture
12.22.06 | Genocea raises initial funding from Lux Capital & Polaris Venture Partners
03.20.06 | Higgins' research featured in Harvard Medical School Press Release - Novel Vaccine Approach Stimulates Protective Immunity Against Listeria
03.01.06 | Darren Higgins profiled in Harvard Magazine
08.15.05 | Darren Higgins featured in The Boston Globe
|
